FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maria Marone

Research Profile

Disorders

Ovarian Neoplasms

Anatomy

Chemicals & Drugs

Phenomena

Physiology

Procedures

Immunophenotyping

Co-author Network

Publications

TOP 3
Giuseppina Bonanno; Alessandro Perillo; Sergio Rutella; Daniela Giovanna De Ritis; Andrea Mariotti; Maria Marone; Franco Meoni; Giovanni Scambia; Giuseppe Leone; Salvatore Mancuso; Luca Pierelli
Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells.
Sergio Rutella; Giuseppina Bonanno; Maria Marone; Daniela G De Ritis; Andrea Mariotti; Maria Teresa Voso; Giovanni Scambia; Salvatore Mancuso; Giuseppe Leone; Luca Pierelli
Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
Luca Pierelli; Maria Marone; Giuseppina Bonanno; Sergio Rutella; Daniela G De Ritis; Salvatore Mancuso; Giuseppe Leone; Giovanni Scambia
Transforming growth factor-beta1 causes transcriptional activation of CD34 and preserves haematopoietic stem/progenitor cell activity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maria Marone (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Giuseppina Bonanno; Alessandro Perillo; Sergio Rutella; Daniela Giovanna De Ritis; Andrea Mariotti; Maria Marone; Franco Meoni; Giovanni Scambia; Giuseppe Leone; Salvatore Mancuso; Luca Pierelli
Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells.
Transfusion 2004;44(7):1087-97.
2003: Sergio Rutella; Giuseppina Bonanno; Maria Marone; Daniela G De Ritis; Andrea Mariotti; Maria Teresa Voso; Giovanni Scambia; Salvatore Mancuso; Giuseppe Leone; Luca Pierelli
Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(6):2977-88.
2002: Luca Pierelli; Maria Marone; Giuseppina Bonanno; Sergio Rutella; Daniela G De Ritis; Salvatore Mancuso; Giuseppe Leone; Giovanni Scambia
Transforming growth factor-beta1 causes transcriptional activation of CD34 and preserves haematopoietic stem/progenitor cell activity.
British journal of haematology 2002;118(2):627-37.
2002: Maria Marone; Daniela G De Ritis; Giuseppina Bonanno; Simona Mozzetti; Sergio Rutella; Giovanni Scambia; Luca Pierelli
Cell cycle regulation in human hematopoietic stem cells: from isolation to activation.
Leukemia & lymphoma 2002;43(3):493-501.
2002: Maria Marone; Giuseppina Bonanno; Sergio Rutella; Giuseppe Leone; Giovanni Scambia; Luca Pierelli
Survival and cell cycle control in early hematopoiesis: role of bcl-2, and the cyclin dependent kinase inhibitors P27 and P21.
Leukemia & lymphoma 2002;43(1):51-7.
2002: Maria Marone; G Scambia; G Bonanno; Sergio Rutella; Daniela G De Ritis; F Guidi; Giuseppe Leone; L Pierelli
Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
Leukemia 2002;16(1):94-105.
2001: Luca Pierelli; Giuseppina Bonanno; Sergio Rutella; Maria Marone; G Scambia; G Leone
CD105 (endoglin) expression on hematopoietic stem/progenitor cells.
Leukemia & lymphoma 2001;42(6):1195-206.
2001: Maria Marone; G D'Andrilli; N Das; Ferlini Cristiano; S Chatterjee; G Scambia
Quercetin abrogates taxol-mediated signaling by inhibiting multiple kinases.
Experimental cell research 2001;270(1):1-12.
2001: Sergio Rutella; Luca Pierelli; Carlo Rumi; Giuseppina Bonanno; Maria Marone; Simona Sica; Ettore Capoluongo; F Ameglio; Giovanni Scambia; Giuseppe Leone
T-cell apoptosis induced by granulocyte colony-stimulating factor is associated with retinoblastoma protein phosphorylation and reduced expression of cyclin-dependent kinase inhibitors.
Experimental hematology 2001;29(4):401-15.
2000: Maria Marone; Luca Pierelli; Simona Mozzetti; Valeria Masciullo; Giuseppina Bonanno; Roberta Morosetti; Sergio Rutella; Alessandra Battaglia; Carlo Rumi; Salvatore Mancuso; Giuseppe Leone; Antonio Giordano; Giovanni Scambia
High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-expressing CD34+-proliferating haematopoietic progenitors.
British journal of haematology 2000;110(3):654-62.
2000: Gabriella Ferrandina; Simona Mozzetti; Maria Marone; A Fagotti; Gabriella Macchia; Salvatore Mancuso; Giovanni Scambia
Bcl-2, bax, bcl-x(L) and bcl-x(S) expression in neoplastic and normal cervical tissue.
Cancer letters 2000;155(1):19-27.
2000: Luca Pierelli; Maria Marone; Giuseppina Bonanno; Simona Mozzetti; Sergio Rutella; Roberta Morosetti; Carlo Rumi; Salvatore Mancuso; Giuseppe Leone; Giovanni Scambia
Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-beta1 is a cell cycle-independent effect and influences their hematopoietic potential.
Blood 2000;95(10):3001-9.
2000: Alessandra Battaglia; Andrea Fattorossi; Luca Pierelli; Giuseppina Bonanno; Maria Marone; Franco O Ranelletti; Annamaria Coscarella; Rita De Santis; S Bach; S Mancuso; Giovanni Scambia
The fusion protein MEN 11303 (granulocyte-macrophage colony stimulating factor/erythropoietin) acts as a potent inducer of erythropoiesis.
Experimental hematology 2000;28(5):490-8.
2000: Luca Pierelli; Giovanni Scambia; Giuseppina Bonanno; Sergio Rutella; Pierluigi Puggioni; Alessandra Battaglia; Simona Mozzetti; Maria Marone; G Menichella; Carlo Rumi; Salvatore Mancuso; Giuseppe Leone
CD34+/CD105+ cells are enriched in primitive circulating progenitors residing in the G0 phase of the cell cycle and contain all bone marrow and cord blood CD34+/CD38low/- precursors.
British journal of haematology 2000;108(3):610-20.
2000: Maria Marone; Gabriella Ferrandina; Gabriella Macchia; Simona Mozzetti; A De Pasqua; Pierluigi Benedetti Panici; Salvatore Mancuso; Giovanni Scambia
Bcl-2, Bax, Bcl-x(L) and Bcl-x(S) expression in neoplastic and normal endometrium.
Oncology 2000;58(2):161-8.
2000: Simona Mozzetti; Gabriella Ferrandina; Maria Marone; F D'Ingiullo; Erika Fruscella; A De Pasqua; Salvatore Mancuso; Giovanni Scambia
Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues.
Cancer detection and prevention 2000;24(6):536-41.
1999: Alfredo Ercoli; Gabriella Ferrandina; Giuseppina Raspaglio; Maria Marone; N Maggiano; P Del Mastro; Pierluigi Benedetti Panici; Salvatore Mancuso; Giovanni Scambia
hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer.
British journal of cancer 1999;80(10):1665-71.
1999: Ferlini Cristiano; Giovanni Scambia; Maria Marone; Mariagrazia Distefano; C Gaggini; Gabriella Ferrandina; Andrea Fattorossi; G Isola; Pierluigi Benedetti Panici; Salvatore Mancuso
Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines.
British journal of cancer 1999;79(2):257-63.
1998: Luca Pierelli; Giovanni Scambia; Andrea Fattorossi; Giuseppina Bonanno; Alessandra Battaglia; Carlo Rumi; Maria Marone; Simona Mozzetti; Sergio Rutella; G Menichella; V Romeo; Salvatore Mancuso; Giuseppe Leone
Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ haemopoietic progenitors.
British journal of haematology 1998;102(5):1139-50.
1998: Maria Marone; Giovanni Scambia; Simona Mozzetti; Gabriella Ferrandina; S Iacovella; A De Pasqua; Pierluigi Benedetti Panici; Salvatore Mancuso
bcl-2, bax, bcl-XL, and bcl-XS expression in normal and neoplastic ovarian tissues.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):517-24.
1998: Maria Marone; Giovanni Scambia; C Giannitelli; Gabriella Ferrandina; Valeria Masciullo; Alfonso Bellacosa; Pierluigi Benedetti Panici; Salvatore Mancuso
Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression.
International journal of cancer. Journal international du cancer 1998;75(1):34-9.
1998: Nicola Garcea; S Campo; Maria Marone; Riccardo Garcea
Spontaneous pregnancy after 13 years of amenorrhea in a patient with a voluminous ovarian dysgerminoma and submitted to left adnexectomy and radiotherapy.
Gynecologic and obstetric investigation 1998;46(3):214-6.
1997: Valeria Masciullo; G Scambia; Maria Marone; C Giannitelli; Gabriella Ferrandina; Alfonso Bellacosa; Pierluigi Benedetti Panici; S Mancuso
Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas.
International journal of cancer. Journal international du cancer 1997;74(4):390-5.
1997: Giovanni Scambia; Valeria Masciullo; Pierluigi Benedetti Panici; Maria Marone; Gabriella Ferrandina; N Todaro; A Bellacosa; S K Jain; G Neri; A Piffanelli; Salvatore Mancuso
Prognostic significance of ras/p21 alterations in human ovarian cancer.
British journal of cancer 1997;75(10):1547-53.
1996: Maria Marone; Giovanni Scambia; Gabriella Ferrandina; C Giannitelli; Pierluigi Benedetti Panici; S Iacovella; A Leone; Salvatore Mancuso
Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.
British journal of cancer 1996;74(7):1063-8.
1996: Gabriella Ferrandina; Giovanni Scambia; Maria Marone; Pierluigi Benedetti Panici; C Giannitelli; S Pernisco; F Coronetta; Salvatore Mancuso
NM23 in Ovarian Cancer. Correlation with clinicopathological and biochemical parameters.
Annals of the New York Academy of Sciences 1996;784():509-12.
1996: Giovanni Scambia; Gabriella Ferrandina; Maria Marone; Pierluigi Benedetti Panici; C Giannitelli; M Piantelli; A Leone; Salvatore Mancuso
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):334-42.